Related Experiment Video
Updated: Jan 14, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
The fungus among us: Emerging and re-emerging fungal infections
Jonathan Huang1, Nora Oliver2, Lucy S Witt1
1Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA, USA.
Abstract:
The landscape of fungal infections is rapidly evolving. The global rise in incidence of fungal disease and the increasing prevalence of antifungal resistance can be attributed to shifting host factors and changes in pathogen dynamics. Candida species have shown increasing rates of invasive disease. This is accompanied by a growing number of resistant species, including Candida auris. While dermatophytes remain the most common cause of fungal disease, novel resistant species are emerging as a major cause of recalcitrant infections. Endemic mycoses are expanding beyond their previously defined geographic ranges, with newly recognized genera such as Emergomyces. Similarly, more resistant mold infections are affecting an increasingly immunocompromised patient population. These opportunistic fungal pathogens continue to be a major source of worldwide morbidity and mortality. Addressing this challenge requires an improved understanding of fungal epidemiology, a commitment to protecting vulnerable patients, and the development of novel antifungal agents.
Insights
Fungal infections are increasing globally, with rising antifungal resistance and new resistant species like Candida auris emerging. Addressing this requires better understanding, patient protection, and new antifungal treatments.
Area of Science:
- Mycology
- Infectious Diseases
- Epidemiology
Background:
- The global incidence of fungal diseases and antifungal resistance is rising due to evolving host factors and pathogen dynamics.
- Increasing rates of invasive disease are observed with Candida species, including the emergence of resistant strains like Candida auris.
- Novel resistant fungal species and expanding endemic mycoses pose significant threats, particularly to immunocompromised individuals.
Purpose of the Study:
- To highlight the evolving landscape of fungal infections.
- To underscore the growing challenge of antifungal resistance.
- To emphasize the need for novel antifungal strategies.
Main Methods:
- Review of current epidemiological trends in fungal infections.
- Analysis of emerging resistant fungal species and their clinical impact.
- Assessment of geographic expansion of endemic mycoses.
Main Results:
- Candida species, including Candida auris, show increasing invasive disease and resistance.
- Novel resistant species are causing recalcitrant infections, alongside expanding endemic mycoses.
- Resistant mold infections are increasingly affecting immunocompromised populations.
Conclusions:
- Fungal infections represent a major global health challenge with increasing morbidity and mortality.
- Urgent need for enhanced understanding of fungal epidemiology.
- Development of novel antifungal agents and improved patient protection strategies are critical.
Related Concept Videos
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Overview of Fungi
Fungal Phylum Basidiomycota

